Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion description "[In conclusion, our data, for the first time, demonstrate that MCT1 inhibition has antitumor potential which is associated with the NF-?B pathway, and high MCT1 expression predicates poor overall survival in patients with osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion evidence source_evidence_literature NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion SIO_000772 24012639 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion wasDerivedFrom befree-2016 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion wasGeneratedBy ECO_0000203 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.